| Neuroinflammation: friend and foe for ischemic stroke |
90 |
| The role of inflammation in the development of epilepsy |
67 |
| MOG encephalomyelitis: international recommendations on diagnosis and antibody testing |
62 |
| Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis |
55 |
| Inflammation: the link between comorbidities, genetics, and Alzheimer's disease |
47 |
| Necroptosis: a regulated inflammatory mode of cell death |
45 |
| Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats |
44 |
| Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles |
38 |
| Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway |
35 |
| Glial activation and inflammation along the Alzheimer's disease continuum |
34 |
| Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury |
33 |
| Long noncoding RNA MALAT1 in exosomes drives regenerative function and modulates inflammation-linked networks following traumatic brain injury |
33 |
| Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-kappa B pathway following experimental traumatic brain injury |
33 |
| Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-kappa B pathway dependent of HDAC3 |
31 |
| Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway |
30 |
| Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats |
29 |
| Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease |
29 |
| Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease |
28 |
| Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis |
27 |
| Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease |
26 |
| In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation |
26 |
| The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease |
26 |
| Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration |
25 |
| A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury |
25 |
| IRE1 alpha inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats |
23 |
| Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3 beta/Nrf2 signaling |
23 |
| The endotoxin hypothesis of neurodegeneration |
23 |
| Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in mice |
22 |
| The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation |
22 |
| Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+Th1/Th2/T17 and Treg in drug-naive and drugtreated patients |
22 |
| Inflammation leads to distinct populations of extracellular vesicles from microglia |
22 |
| LncRNA H19 contributes to hippocampal glial cell activation via JAK/STAT signaling in a rat model of temporal lobe epilepsy |
21 |
| Neuroinflammation and fractalkine signaling in Alzheimer's disease |
21 |
| An update on reactive astrocytes in chronic pain |
21 |
| Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo |
21 |
| Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta |
21 |
| Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation |
20 |
| Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice |
20 |
| Sphingosine 1-phosphate receptor subtype 3 (S1P(3)) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization |
20 |
| Antibiotics, gut microbiota, and Alzheimer's disease |
20 |
| The role of microglia in viral encephalitis: a review |
20 |
| Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice |
19 |
| Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? |
19 |
| miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis |
19 |
| Acute dose of melatonin via Nrf2 dependently prevents acute ethanol-induced neurotoxicity in the developing rodent brain |
19 |
| NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes |
19 |
| Reactive microglia and IL1/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse retina |
19 |
| Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice |
19 |
| Microglial NLRP3 inflammasome activation mediates IL-1 beta release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model |
19 |
| Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPAR/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats |
19 |
